Intellia Therapeutics Inc (NTLA)

Operating Expenses

$395.82M

TTM · Period ending: · USD

NTLA logo

NTLA Operating Expenses

Latest reported$395.82M
NTLA TTM Operating Expenses ($19.45M → $395.82M)
High-resolution chart · PNG

NTLA operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Intellia Therapeutics Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
395,819,000
319,108,000
343,164,000
259,896,000
258,293,000
357,986,000
360,978,000
464,043,000
560,145,000
447,396,000
334,418,000
222,535,000
103,871,000
95,351,000
90,306,000
88,788,000
85,354,000
79,905,000
71,096,000
59,751,000
51,606,000
46,449,000
44,169,000
42,382,000
67,760,000
94,812,000
117,740,000
137,390,000
132,953,000
125,647,000
121,304,000
124,061,000
115,746,000
106,408,000
95,672,000
80,738,000
70,112,000
59,330,000
48,638,000
39,373,000
31,796,000
25,443,000
19,453,000
18,011,000
13,189,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.